nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—Anaemia megaloblastic—Azathioprine—multiple sclerosis	0.0361	0.0869	CcSEcCtD
Secobarbital—CHRNA4—peripheral nervous system—multiple sclerosis	0.0297	0.0543	CbGeAlD
Secobarbital—GRIK2—nerve—multiple sclerosis	0.0288	0.0527	CbGeAlD
Secobarbital—CHRNA4—nerve—multiple sclerosis	0.0231	0.0424	CbGeAlD
Secobarbital—Liver injury—Fingolimod—multiple sclerosis	0.0219	0.0528	CcSEcCtD
Secobarbital—Anaemia megaloblastic—Methotrexate—multiple sclerosis	0.0145	0.035	CcSEcCtD
Secobarbital—GRIA2—brainstem—multiple sclerosis	0.0137	0.025	CbGeAlD
Secobarbital—GABRA6—brainstem—multiple sclerosis	0.0132	0.0242	CbGeAlD
Secobarbital—GRIK2—brainstem—multiple sclerosis	0.0124	0.0226	CbGeAlD
Secobarbital—GRIK2—retina—multiple sclerosis	0.0119	0.0218	CbGeAlD
Secobarbital—Injection site reaction—Cladribine—multiple sclerosis	0.0104	0.025	CcSEcCtD
Secobarbital—Liver injury—Azathioprine—multiple sclerosis	0.0101	0.0243	CcSEcCtD
Secobarbital—Depressed level of consciousness—Cladribine—multiple sclerosis	0.0101	0.0243	CcSEcCtD
Secobarbital—CHRNA4—brainstem—multiple sclerosis	0.00993	0.0182	CbGeAlD
Secobarbital—GABRB2—brainstem—multiple sclerosis	0.00973	0.0178	CbGeAlD
Secobarbital—CHRNA7—retina—multiple sclerosis	0.00971	0.0178	CbGeAlD
Secobarbital—Bradycardia—Fingolimod—multiple sclerosis	0.00943	0.0227	CcSEcCtD
Secobarbital—GABRA2—brainstem—multiple sclerosis	0.00889	0.0163	CbGeAlD
Secobarbital—GRIA2—midbrain—multiple sclerosis	0.00872	0.016	CbGeAlD
Secobarbital—GRIK2—medulla oblongata—multiple sclerosis	0.00862	0.0158	CbGeAlD
Secobarbital—GABRA1—brainstem—multiple sclerosis	0.00859	0.0157	CbGeAlD
Secobarbital—Hepatocellular injury—Azathioprine—multiple sclerosis	0.00851	0.0205	CcSEcCtD
Secobarbital—GRIA2—spinal cord—multiple sclerosis	0.00851	0.0156	CbGeAlD
Secobarbital—GRIK2—midbrain—multiple sclerosis	0.00788	0.0144	CbGeAlD
Secobarbital—GRIK2—spinal cord—multiple sclerosis	0.00768	0.0141	CbGeAlD
Secobarbital—GRIA2—nervous system—multiple sclerosis	0.00717	0.0131	CbGeAlD
Secobarbital—Ataxia—Cladribine—multiple sclerosis	0.00714	0.0172	CcSEcCtD
Secobarbital—GABRA6—nervous system—multiple sclerosis	0.00692	0.0127	CbGeAlD
Secobarbital—GRIA2—central nervous system—multiple sclerosis	0.0069	0.0126	CbGeAlD
Secobarbital—GABRG2—medulla oblongata—multiple sclerosis	0.00678	0.0124	CbGeAlD
Secobarbital—GABRB2—medulla oblongata—multiple sclerosis	0.00678	0.0124	CbGeAlD
Secobarbital—GRIA2—cerebellum—multiple sclerosis	0.00674	0.0123	CbGeAlD
Secobarbital—GABRA5—nervous system—multiple sclerosis	0.00672	0.0123	CbGeAlD
Secobarbital—GABRA6—central nervous system—multiple sclerosis	0.00667	0.0122	CbGeAlD
Secobarbital—CHRFAM7A—nervous system—multiple sclerosis	0.00653	0.012	CbGeAlD
Secobarbital—GABRA6—cerebellum—multiple sclerosis	0.00652	0.0119	CbGeAlD
Secobarbital—GRIK2—nervous system—multiple sclerosis	0.00648	0.0119	CbGeAlD
Secobarbital—GABRA5—central nervous system—multiple sclerosis	0.00647	0.0118	CbGeAlD
Secobarbital—CHRNA4—midbrain—multiple sclerosis	0.00633	0.0116	CbGeAlD
Secobarbital—CHRFAM7A—central nervous system—multiple sclerosis	0.00629	0.0115	CbGeAlD
Secobarbital—GABRA3—nervous system—multiple sclerosis	0.00625	0.0114	CbGeAlD
Secobarbital—GRIK2—central nervous system—multiple sclerosis	0.00623	0.0114	CbGeAlD
Secobarbital—GABRG2—midbrain—multiple sclerosis	0.0062	0.0114	CbGeAlD
Secobarbital—GABRB2—midbrain—multiple sclerosis	0.0062	0.0114	CbGeAlD
Secobarbital—CHRNA4—spinal cord—multiple sclerosis	0.00618	0.0113	CbGeAlD
Secobarbital—Hypotension—Fingolimod—multiple sclerosis	0.00615	0.0148	CcSEcCtD
Secobarbital—GABRA4—nervous system—multiple sclerosis	0.00609	0.0112	CbGeAlD
Secobarbital—GRIK2—cerebellum—multiple sclerosis	0.00609	0.0112	CbGeAlD
Secobarbital—GABRB2—spinal cord—multiple sclerosis	0.00605	0.0111	CbGeAlD
Secobarbital—GABRG2—spinal cord—multiple sclerosis	0.00605	0.0111	CbGeAlD
Secobarbital—GABRA3—central nervous system—multiple sclerosis	0.00602	0.011	CbGeAlD
Secobarbital—GABRA1—medulla oblongata—multiple sclerosis	0.00599	0.011	CbGeAlD
Secobarbital—GABRA4—central nervous system—multiple sclerosis	0.00587	0.0107	CbGeAlD
Secobarbital—GABRA4—cerebellum—multiple sclerosis	0.00573	0.0105	CbGeAlD
Secobarbital—GRIA2—brain—multiple sclerosis	0.00548	0.01	CbGeAlD
Secobarbital—GABRA1—midbrain—multiple sclerosis	0.00548	0.01	CbGeAlD
Secobarbital—Hypoxia—Methotrexate—multiple sclerosis	0.00539	0.013	CcSEcCtD
Secobarbital—GABRA1—spinal cord—multiple sclerosis	0.00534	0.00978	CbGeAlD
Secobarbital—GABRA6—brain—multiple sclerosis	0.00529	0.00969	CbGeAlD
Secobarbital—CHRNA7—nervous system—multiple sclerosis	0.00527	0.00966	CbGeAlD
Secobarbital—CHRNA4—nervous system—multiple sclerosis	0.0052	0.00953	CbGeAlD
Secobarbital—GABRA5—brain—multiple sclerosis	0.00513	0.0094	CbGeAlD
Secobarbital—GABRB2—nervous system—multiple sclerosis	0.0051	0.00933	CbGeAlD
Secobarbital—GABRG2—nervous system—multiple sclerosis	0.0051	0.00933	CbGeAlD
Secobarbital—CHRNA7—central nervous system—multiple sclerosis	0.00508	0.0093	CbGeAlD
Secobarbital—CHRNA4—central nervous system—multiple sclerosis	0.00501	0.00917	CbGeAlD
Secobarbital—CHRFAM7A—brain—multiple sclerosis	0.00499	0.00914	CbGeAlD
Secobarbital—GRIK2—brain—multiple sclerosis	0.00495	0.00906	CbGeAlD
Secobarbital—GABRG2—central nervous system—multiple sclerosis	0.00491	0.00899	CbGeAlD
Secobarbital—GABRB2—central nervous system—multiple sclerosis	0.00491	0.00899	CbGeAlD
Secobarbital—CHRNA4—cerebellum—multiple sclerosis	0.0049	0.00897	CbGeAlD
Secobarbital—GABRB2—cerebellum—multiple sclerosis	0.0048	0.00878	CbGeAlD
Secobarbital—GABRG2—cerebellum—multiple sclerosis	0.0048	0.00878	CbGeAlD
Secobarbital—GABRA3—brain—multiple sclerosis	0.00478	0.00875	CbGeAlD
Secobarbital—GABRA4—brain—multiple sclerosis	0.00466	0.00853	CbGeAlD
Secobarbital—GABRA2—nervous system—multiple sclerosis	0.00466	0.00853	CbGeAlD
Secobarbital—GABRA1—nervous system—multiple sclerosis	0.0045	0.00824	CbGeAlD
Secobarbital—GABRA2—central nervous system—multiple sclerosis	0.00448	0.00821	CbGeAlD
Secobarbital—GABRA2—cerebellum—multiple sclerosis	0.00438	0.00802	CbGeAlD
Secobarbital—Dizziness—Fingolimod—multiple sclerosis	0.00435	0.0105	CcSEcCtD
Secobarbital—GABRA1—central nervous system—multiple sclerosis	0.00433	0.00793	CbGeAlD
Secobarbital—GABRA1—cerebellum—multiple sclerosis	0.00424	0.00776	CbGeAlD
Secobarbital—Headache—Fingolimod—multiple sclerosis	0.00412	0.00993	CcSEcCtD
Secobarbital—Apnoea—Methotrexate—multiple sclerosis	0.00404	0.00973	CcSEcCtD
Secobarbital—CHRNA7—brain—multiple sclerosis	0.00403	0.00738	CbGeAlD
Secobarbital—CHRNA4—brain—multiple sclerosis	0.00398	0.00728	CbGeAlD
Secobarbital—GABRB2—brain—multiple sclerosis	0.0039	0.00713	CbGeAlD
Secobarbital—GABRG2—brain—multiple sclerosis	0.0039	0.00713	CbGeAlD
Secobarbital—Anxiety—Cladribine—multiple sclerosis	0.00388	0.00934	CcSEcCtD
Secobarbital—Confusional state—Cladribine—multiple sclerosis	0.00376	0.00906	CcSEcCtD
Secobarbital—Hyperkinesia—Prednisone—multiple sclerosis	0.00358	0.00861	CcSEcCtD
Secobarbital—GABRA2—brain—multiple sclerosis	0.00356	0.00652	CbGeAlD
Secobarbital—Bradycardia—Mitoxantrone—multiple sclerosis	0.00352	0.00846	CcSEcCtD
Secobarbital—Respiratory failure—Methotrexate—multiple sclerosis	0.00349	0.0084	CcSEcCtD
Secobarbital—Hypotension—Cladribine—multiple sclerosis	0.00349	0.0084	CcSEcCtD
Secobarbital—GABRA1—brain—multiple sclerosis	0.00344	0.0063	CbGeAlD
Secobarbital—Somnolence—Cladribine—multiple sclerosis	0.00332	0.00799	CcSEcCtD
Secobarbital—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.00331	0.00797	CcSEcCtD
Secobarbital—Constipation—Cladribine—multiple sclerosis	0.00319	0.00768	CcSEcCtD
Secobarbital—Feeling abnormal—Cladribine—multiple sclerosis	0.00308	0.00741	CcSEcCtD
Secobarbital—Body temperature increased—Cladribine—multiple sclerosis	0.00295	0.0071	CcSEcCtD
Secobarbital—Bradycardia—Prednisolone—multiple sclerosis	0.00288	0.00694	CcSEcCtD
Secobarbital—Hypotension—Azathioprine—multiple sclerosis	0.00284	0.00683	CcSEcCtD
Secobarbital—Hypersensitivity—Cladribine—multiple sclerosis	0.00275	0.00662	CcSEcCtD
Secobarbital—Bradycardia—Triamcinolone—multiple sclerosis	0.00265	0.00639	CcSEcCtD
Secobarbital—Bradycardia—Methylprednisolone—multiple sclerosis	0.00265	0.00637	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.00264	0.00635	CcSEcCtD
Secobarbital—Hallucination—Methylprednisolone—multiple sclerosis	0.00259	0.00623	CcSEcCtD
Secobarbital—Anxiety—Mitoxantrone—multiple sclerosis	0.00255	0.00614	CcSEcCtD
Secobarbital—Feeling abnormal—Azathioprine—multiple sclerosis	0.0025	0.00602	CcSEcCtD
Secobarbital—Confusional state—Mitoxantrone—multiple sclerosis	0.00247	0.00596	CcSEcCtD
Secobarbital—Dizziness—Cladribine—multiple sclerosis	0.00247	0.00594	CcSEcCtD
Secobarbital—Shock—Mitoxantrone—multiple sclerosis	0.00241	0.00581	CcSEcCtD
Secobarbital—Bradycardia—Dexamethasone—multiple sclerosis	0.00241	0.00579	CcSEcCtD
Secobarbital—Bradycardia—Betamethasone—multiple sclerosis	0.00241	0.00579	CcSEcCtD
Secobarbital—Body temperature increased—Azathioprine—multiple sclerosis	0.0024	0.00578	CcSEcCtD
Secobarbital—Vomiting—Cladribine—multiple sclerosis	0.00237	0.00571	CcSEcCtD
Secobarbital—Rash—Cladribine—multiple sclerosis	0.00235	0.00567	CcSEcCtD
Secobarbital—Hallucination—Dexamethasone—multiple sclerosis	0.00235	0.00566	CcSEcCtD
Secobarbital—Hallucination—Betamethasone—multiple sclerosis	0.00235	0.00566	CcSEcCtD
Secobarbital—Dermatitis—Cladribine—multiple sclerosis	0.00235	0.00566	CcSEcCtD
Secobarbital—Ataxia—Methotrexate—multiple sclerosis	0.00234	0.00563	CcSEcCtD
Secobarbital—Headache—Cladribine—multiple sclerosis	0.00234	0.00563	CcSEcCtD
Secobarbital—Hypotension—Mitoxantrone—multiple sclerosis	0.00229	0.00552	CcSEcCtD
Secobarbital—CYP2C8—brain—multiple sclerosis	0.00226	0.00414	CbGeAlD
Secobarbital—Angioedema—Prednisolone—multiple sclerosis	0.00225	0.00543	CcSEcCtD
Secobarbital—Hypersensitivity—Azathioprine—multiple sclerosis	0.00224	0.00538	CcSEcCtD
Secobarbital—Nausea—Cladribine—multiple sclerosis	0.00222	0.00534	CcSEcCtD
Secobarbital—Syncope—Prednisolone—multiple sclerosis	0.00221	0.00532	CcSEcCtD
Secobarbital—Somnolence—Mitoxantrone—multiple sclerosis	0.00218	0.00525	CcSEcCtD
Secobarbital—Loss of consciousness—Prednisolone—multiple sclerosis	0.00217	0.00522	CcSEcCtD
Secobarbital—Constipation—Mitoxantrone—multiple sclerosis	0.0021	0.00505	CcSEcCtD
Secobarbital—Bradycardia—Prednisone—multiple sclerosis	0.0021	0.00505	CcSEcCtD
Secobarbital—Angioedema—Triamcinolone—multiple sclerosis	0.00207	0.00499	CcSEcCtD
Secobarbital—Angioedema—Methylprednisolone—multiple sclerosis	0.00207	0.00498	CcSEcCtD
Secobarbital—Hallucination—Prednisone—multiple sclerosis	0.00205	0.00493	CcSEcCtD
Secobarbital—Syncope—Triamcinolone—multiple sclerosis	0.00203	0.0049	CcSEcCtD
Secobarbital—Syncope—Methylprednisolone—multiple sclerosis	0.00203	0.00489	CcSEcCtD
Secobarbital—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00202	0.00487	CcSEcCtD
Secobarbital—Dizziness—Azathioprine—multiple sclerosis	0.00201	0.00483	CcSEcCtD
Secobarbital—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00199	0.0048	CcSEcCtD
Secobarbital—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00199	0.00479	CcSEcCtD
Secobarbital—Shock—Prednisolone—multiple sclerosis	0.00198	0.00477	CcSEcCtD
Secobarbital—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00194	0.00467	CcSEcCtD
Secobarbital—Vomiting—Azathioprine—multiple sclerosis	0.00193	0.00465	CcSEcCtD
Secobarbital—Anxiety—Methylprednisolone—multiple sclerosis	0.00192	0.00462	CcSEcCtD
Secobarbital—Rash—Azathioprine—multiple sclerosis	0.00191	0.00461	CcSEcCtD
Secobarbital—Dermatitis—Azathioprine—multiple sclerosis	0.00191	0.0046	CcSEcCtD
Secobarbital—Headache—Azathioprine—multiple sclerosis	0.0019	0.00458	CcSEcCtD
Secobarbital—Angioedema—Betamethasone—multiple sclerosis	0.00188	0.00453	CcSEcCtD
Secobarbital—Angioedema—Dexamethasone—multiple sclerosis	0.00188	0.00453	CcSEcCtD
Secobarbital—Confusional state—Methylprednisolone—multiple sclerosis	0.00186	0.00448	CcSEcCtD
Secobarbital—Syncope—Dexamethasone—multiple sclerosis	0.00185	0.00444	CcSEcCtD
Secobarbital—Syncope—Betamethasone—multiple sclerosis	0.00185	0.00444	CcSEcCtD
Secobarbital—Shock—Triamcinolone—multiple sclerosis	0.00182	0.00438	CcSEcCtD
Secobarbital—Shock—Methylprednisolone—multiple sclerosis	0.00182	0.00437	CcSEcCtD
Secobarbital—Loss of consciousness—Betamethasone—multiple sclerosis	0.00181	0.00435	CcSEcCtD
Secobarbital—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00181	0.00435	CcSEcCtD
Secobarbital—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00181	0.00435	CcSEcCtD
Secobarbital—Nausea—Azathioprine—multiple sclerosis	0.0018	0.00434	CcSEcCtD
Secobarbital—Anxiety—Betamethasone—multiple sclerosis	0.00175	0.0042	CcSEcCtD
Secobarbital—Anxiety—Dexamethasone—multiple sclerosis	0.00175	0.0042	CcSEcCtD
Secobarbital—Hypotension—Methylprednisolone—multiple sclerosis	0.00173	0.00415	CcSEcCtD
Secobarbital—Feeling abnormal—Prednisolone—multiple sclerosis	0.00166	0.00399	CcSEcCtD
Secobarbital—Shock—Dexamethasone—multiple sclerosis	0.00165	0.00398	CcSEcCtD
Secobarbital—Shock—Betamethasone—multiple sclerosis	0.00165	0.00398	CcSEcCtD
Secobarbital—Agitation—Prednisone—multiple sclerosis	0.00165	0.00397	CcSEcCtD
Secobarbital—Angioedema—Prednisone—multiple sclerosis	0.00164	0.00394	CcSEcCtD
Secobarbital—Syncope—Prednisone—multiple sclerosis	0.00161	0.00387	CcSEcCtD
Secobarbital—Loss of consciousness—Prednisone—multiple sclerosis	0.00158	0.00379	CcSEcCtD
Secobarbital—Hypotension—Betamethasone—multiple sclerosis	0.00157	0.00378	CcSEcCtD
Secobarbital—Hypotension—Dexamethasone—multiple sclerosis	0.00157	0.00378	CcSEcCtD
Secobarbital—Vomiting—Mitoxantrone—multiple sclerosis	0.00156	0.00376	CcSEcCtD
Secobarbital—Rash—Mitoxantrone—multiple sclerosis	0.00155	0.00372	CcSEcCtD
Secobarbital—Dermatitis—Mitoxantrone—multiple sclerosis	0.00155	0.00372	CcSEcCtD
Secobarbital—Headache—Mitoxantrone—multiple sclerosis	0.00154	0.0037	CcSEcCtD
Secobarbital—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00153	0.00367	CcSEcCtD
Secobarbital—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00152	0.00366	CcSEcCtD
Secobarbital—Anxiety—Prednisone—multiple sclerosis	0.00152	0.00366	CcSEcCtD
Secobarbital—Hypersensitivity—Prednisolone—multiple sclerosis	0.00148	0.00357	CcSEcCtD
Secobarbital—Body temperature increased—Triamcinolone—multiple sclerosis	0.00146	0.00352	CcSEcCtD
Secobarbital—Nausea—Mitoxantrone—multiple sclerosis	0.00146	0.00351	CcSEcCtD
Secobarbital—Shock—Prednisone—multiple sclerosis	0.00144	0.00346	CcSEcCtD
Secobarbital—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00138	0.00333	CcSEcCtD
Secobarbital—Feeling abnormal—Betamethasone—multiple sclerosis	0.00138	0.00333	CcSEcCtD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00138	0.0358	CbGpPWpGaD
Secobarbital—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00136	0.00328	CcSEcCtD
Secobarbital—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00136	0.00328	CcSEcCtD
Secobarbital—Dizziness—Prednisolone—multiple sclerosis	0.00133	0.0032	CcSEcCtD
Secobarbital—Body temperature increased—Dexamethasone—multiple sclerosis	0.00133	0.0032	CcSEcCtD
Secobarbital—Body temperature increased—Betamethasone—multiple sclerosis	0.00133	0.0032	CcSEcCtD
Secobarbital—Rash—Prednisolone—multiple sclerosis	0.00127	0.00306	CcSEcCtD
Secobarbital—Dermatitis—Prednisolone—multiple sclerosis	0.00127	0.00305	CcSEcCtD
Secobarbital—Headache—Prednisolone—multiple sclerosis	0.00126	0.00304	CcSEcCtD
Secobarbital—Constipation—Prednisone—multiple sclerosis	0.00125	0.00301	CcSEcCtD
Secobarbital—Confusional state—Methotrexate—multiple sclerosis	0.00123	0.00297	CcSEcCtD
Secobarbital—Dizziness—Triamcinolone—multiple sclerosis	0.00122	0.00295	CcSEcCtD
Secobarbital—Dizziness—Methylprednisolone—multiple sclerosis	0.00122	0.00294	CcSEcCtD
Secobarbital—Feeling abnormal—Prednisone—multiple sclerosis	0.00121	0.0029	CcSEcCtD
Secobarbital—Nausea—Prednisolone—multiple sclerosis	0.0012	0.00288	CcSEcCtD
Secobarbital—Vomiting—Triamcinolone—multiple sclerosis	0.00118	0.00283	CcSEcCtD
Secobarbital—Vomiting—Methylprednisolone—multiple sclerosis	0.00117	0.00283	CcSEcCtD
Secobarbital—Rash—Triamcinolone—multiple sclerosis	0.00117	0.00281	CcSEcCtD
Secobarbital—Dermatitis—Triamcinolone—multiple sclerosis	0.00117	0.00281	CcSEcCtD
Secobarbital—Rash—Methylprednisolone—multiple sclerosis	0.00116	0.0028	CcSEcCtD
Secobarbital—Dermatitis—Methylprednisolone—multiple sclerosis	0.00116	0.0028	CcSEcCtD
Secobarbital—Headache—Triamcinolone—multiple sclerosis	0.00116	0.00279	CcSEcCtD
Secobarbital—Headache—Methylprednisolone—multiple sclerosis	0.00116	0.00279	CcSEcCtD
Secobarbital—Body temperature increased—Prednisone—multiple sclerosis	0.00116	0.00278	CcSEcCtD
Secobarbital—Hypotension—Methotrexate—multiple sclerosis	0.00114	0.00275	CcSEcCtD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00112	0.0292	CbGpPWpGaD
Secobarbital—Dizziness—Dexamethasone—multiple sclerosis	0.00111	0.00267	CcSEcCtD
Secobarbital—Dizziness—Betamethasone—multiple sclerosis	0.00111	0.00267	CcSEcCtD
Secobarbital—Nausea—Triamcinolone—multiple sclerosis	0.0011	0.00265	CcSEcCtD
Secobarbital—Nausea—Methylprednisolone—multiple sclerosis	0.0011	0.00264	CcSEcCtD
Secobarbital—Somnolence—Methotrexate—multiple sclerosis	0.00109	0.00262	CcSEcCtD
Secobarbital—Hypersensitivity—Prednisone—multiple sclerosis	0.00108	0.00259	CcSEcCtD
Secobarbital—Vomiting—Dexamethasone—multiple sclerosis	0.00107	0.00257	CcSEcCtD
Secobarbital—Vomiting—Betamethasone—multiple sclerosis	0.00107	0.00257	CcSEcCtD
Secobarbital—Rash—Betamethasone—multiple sclerosis	0.00106	0.00255	CcSEcCtD
Secobarbital—Rash—Dexamethasone—multiple sclerosis	0.00106	0.00255	CcSEcCtD
Secobarbital—Dermatitis—Dexamethasone—multiple sclerosis	0.00106	0.00255	CcSEcCtD
Secobarbital—Dermatitis—Betamethasone—multiple sclerosis	0.00106	0.00255	CcSEcCtD
Secobarbital—Headache—Dexamethasone—multiple sclerosis	0.00105	0.00253	CcSEcCtD
Secobarbital—Headache—Betamethasone—multiple sclerosis	0.00105	0.00253	CcSEcCtD
Secobarbital—Feeling abnormal—Methotrexate—multiple sclerosis	0.00101	0.00243	CcSEcCtD
Secobarbital—Nausea—Dexamethasone—multiple sclerosis	0.000998	0.0024	CcSEcCtD
Secobarbital—Nausea—Betamethasone—multiple sclerosis	0.000998	0.0024	CcSEcCtD
Secobarbital—Dizziness—Prednisone—multiple sclerosis	0.000967	0.00233	CcSEcCtD
Secobarbital—Body temperature increased—Methotrexate—multiple sclerosis	0.000966	0.00233	CcSEcCtD
Secobarbital—GRIA2—BDNF signaling pathway—KCNA3—multiple sclerosis	0.000937	0.0243	CbGpPWpGaD
Secobarbital—Vomiting—Prednisone—multiple sclerosis	0.00093	0.00224	CcSEcCtD
Secobarbital—Rash—Prednisone—multiple sclerosis	0.000922	0.00222	CcSEcCtD
Secobarbital—Dermatitis—Prednisone—multiple sclerosis	0.000921	0.00222	CcSEcCtD
Secobarbital—Headache—Prednisone—multiple sclerosis	0.000916	0.00221	CcSEcCtD
Secobarbital—Hypersensitivity—Methotrexate—multiple sclerosis	0.000901	0.00217	CcSEcCtD
Secobarbital—Nausea—Prednisone—multiple sclerosis	0.000869	0.00209	CcSEcCtD
Secobarbital—Dizziness—Methotrexate—multiple sclerosis	0.000808	0.00195	CcSEcCtD
Secobarbital—Vomiting—Methotrexate—multiple sclerosis	0.000777	0.00187	CcSEcCtD
Secobarbital—Rash—Methotrexate—multiple sclerosis	0.000771	0.00186	CcSEcCtD
Secobarbital—Dermatitis—Methotrexate—multiple sclerosis	0.00077	0.00185	CcSEcCtD
Secobarbital—Headache—Methotrexate—multiple sclerosis	0.000766	0.00184	CcSEcCtD
Secobarbital—GRIA2—N-cadherin signaling events—CNR1—multiple sclerosis	0.000754	0.0196	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—LINGO1—multiple sclerosis	0.000749	0.0195	CbGpPWpGaD
Secobarbital—Nausea—Methotrexate—multiple sclerosis	0.000726	0.00175	CcSEcCtD
Secobarbital—GRIK2—Neuronal System—KCNA3—multiple sclerosis	0.000721	0.0187	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000696	0.0181	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—KCNA3—multiple sclerosis	0.000656	0.0171	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000573	0.0149	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—KCNA3—multiple sclerosis	0.000552	0.0143	CbGpPWpGaD
Secobarbital—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000539	0.014	CbGpPWpGaD
Secobarbital—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000539	0.014	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—KCNA3—multiple sclerosis	0.000535	0.0139	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000467	0.0121	CbGpPWpGaD
Secobarbital—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00046	0.012	CbGpPWpGaD
Secobarbital—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00046	0.012	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—KCNA3—multiple sclerosis	0.000459	0.0119	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—KCNA3—multiple sclerosis	0.000453	0.0118	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000434	0.0113	CbGpPWpGaD
Secobarbital—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00042	0.0109	CbGpPWpGaD
Secobarbital—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00042	0.0109	CbGpPWpGaD
Secobarbital—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000415	0.0108	CbGpPWpGaD
Secobarbital—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000415	0.0108	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—KCNA3—multiple sclerosis	0.000414	0.0108	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—KCNA3—multiple sclerosis	0.000403	0.0105	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—KCNA3—multiple sclerosis	0.000395	0.0103	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—KCNA3—multiple sclerosis	0.000388	0.0101	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—KCNA3—multiple sclerosis	0.000379	0.00985	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000354	0.00919	CbGpPWpGaD
Secobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000342	0.00889	CbGpPWpGaD
Secobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000342	0.00889	CbGpPWpGaD
Secobarbital—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000341	0.00885	CbGpPWpGaD
Secobarbital—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000341	0.00885	CbGpPWpGaD
Secobarbital—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000338	0.00877	CbGpPWpGaD
Secobarbital—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000338	0.00877	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—KCNA3—multiple sclerosis	0.000331	0.00861	CbGpPWpGaD
Secobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000292	0.00759	CbGpPWpGaD
Secobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000292	0.00759	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000289	0.00751	CbGpPWpGaD
Secobarbital—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000288	0.00749	CbGpPWpGaD
Secobarbital—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000288	0.00749	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000277	0.0072	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000277	0.0072	CbGpPWpGaD
Secobarbital—GRIK2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000264	0.00686	CbGpPWpGaD
Secobarbital—GRIA2—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000256	0.00664	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000251	0.00651	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—CNR1—multiple sclerosis	0.000249	0.00646	CbGpPWpGaD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00024	0.00624	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000237	0.00616	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000237	0.00616	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000225	0.00583	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000219	0.00569	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000214	0.00557	CbGpPWpGaD
Secobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	0.00021	0.00545	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—BCHE—multiple sclerosis	0.000202	0.00526	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000202	0.00525	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—BDNF—multiple sclerosis	0.000201	0.00523	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000196	0.00509	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—BCHE—multiple sclerosis	0.000184	0.00478	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000183	0.00476	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000181	0.0047	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000181	0.0047	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—SPP1—multiple sclerosis	0.000179	0.00464	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000178	0.00464	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000178	0.00464	CbGpPWpGaD
Secobarbital—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000176	0.00458	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000175	0.00454	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000171	0.00444	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000169	0.00439	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000168	0.00436	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000166	0.00431	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000157	0.00409	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—BCHE—multiple sclerosis	0.000155	0.00402	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000154	0.00401	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000152	0.00394	CbGpPWpGaD
Secobarbital—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000151	0.00391	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—BCHE—multiple sclerosis	0.00015	0.0039	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00015	0.0039	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000147	0.00383	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000147	0.00383	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000147	0.00383	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000147	0.00383	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000145	0.00377	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000145	0.00377	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000145	0.00376	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000145	0.00376	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000142	0.0037	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000141	0.00367	CbGpPWpGaD
Secobarbital—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000139	0.00361	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000139	0.0036	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000137	0.00356	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00013	0.00337	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—BCHE—multiple sclerosis	0.000129	0.00334	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000128	0.00332	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—BCHE—multiple sclerosis	0.000127	0.0033	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000126	0.00327	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000126	0.00327	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000124	0.00323	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000124	0.00323	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000123	0.00321	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000121	0.00315	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000117	0.00304	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—BCHE—multiple sclerosis	0.000116	0.00302	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000114	0.00295	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000113	0.00294	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—BCHE—multiple sclerosis	0.000113	0.00293	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000112	0.00292	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000112	0.0029	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—BCHE—multiple sclerosis	0.000111	0.00288	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00011	0.00285	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—BCHE—multiple sclerosis	0.000109	0.00283	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000108	0.00281	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000107	0.00278	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—BCHE—multiple sclerosis	0.000106	0.00276	CbGpPWpGaD
Secobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000103	0.00267	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000102	0.00266	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000101	0.00263	CbGpPWpGaD
Secobarbital—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.45e-05	0.00246	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.36e-05	0.00243	CbGpPWpGaD
Secobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.34e-05	0.00243	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—BCHE—multiple sclerosis	9.29e-05	0.00241	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.25e-05	0.0024	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	9.16e-05	0.00238	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.06e-05	0.00235	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.99e-05	0.00234	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.94e-05	0.00232	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.83e-05	0.00229	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.67e-05	0.00225	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.46e-05	0.0022	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—STAT3—multiple sclerosis	8.45e-05	0.00219	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.18e-05	0.00212	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—multiple sclerosis	8.16e-05	0.00212	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.94e-05	0.00206	CbGpPWpGaD
Secobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.85e-05	0.00204	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.8e-05	0.00203	CbGpPWpGaD
Secobarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.72e-05	0.00201	CbGpPWpGaD
Secobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.69e-05	0.002	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—MAPK1—multiple sclerosis	7.68e-05	0.00199	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.67e-05	0.00199	CbGpPWpGaD
Secobarbital—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.66e-05	0.00199	CbGpPWpGaD
Secobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.62e-05	0.00198	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.48e-05	0.00194	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.4e-05	0.00192	CbGpPWpGaD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.02e-05	0.00182	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.95e-05	0.00181	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.95e-05	0.00181	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.77e-05	0.00176	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.65e-05	0.00173	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.58e-05	0.00171	CbGpPWpGaD
Secobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.57e-05	0.00171	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.54e-05	0.0017	CbGpPWpGaD
Secobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.53e-05	0.0017	CbGpPWpGaD
Secobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.45e-05	0.00168	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.24e-05	0.00162	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.03e-05	0.00157	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.01e-05	0.00156	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—MAPK1—multiple sclerosis	5.91e-05	0.00154	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.9e-05	0.00153	CbGpPWpGaD
Secobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.9e-05	0.00153	CbGpPWpGaD
Secobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.73e-05	0.00149	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.72e-05	0.00149	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.67e-05	0.00147	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.66e-05	0.00147	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.66e-05	0.00147	CbGpPWpGaD
Secobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.63e-05	0.00146	CbGpPWpGaD
Secobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.53e-05	0.00144	CbGpPWpGaD
Secobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.39e-05	0.0014	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—MAPK1—multiple sclerosis	5.38e-05	0.0014	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.37e-05	0.00139	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.33e-05	0.00138	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.91e-05	0.00128	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.85e-05	0.00126	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.83e-05	0.00126	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.83e-05	0.00126	CbGpPWpGaD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.71e-05	0.00122	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.7e-05	0.00122	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.69e-05	0.00122	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.6e-05	0.00119	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—MAPK1—multiple sclerosis	4.52e-05	0.00118	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.43e-05	0.00115	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SRM—multiple sclerosis	4.39e-05	0.00114	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—MAPK1—multiple sclerosis	4.39e-05	0.00114	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.38e-05	0.00114	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.38e-05	0.00114	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.31e-05	0.00112	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.23e-05	0.0011	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.16e-05	0.00108	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.12e-05	0.00107	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.07e-05	0.00106	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.05e-05	0.00105	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—MAPK1—multiple sclerosis	3.76e-05	0.000977	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—MAPK1—multiple sclerosis	3.71e-05	0.000965	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SRM—multiple sclerosis	3.58e-05	0.000929	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.54e-05	0.000921	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—MAPK1—multiple sclerosis	3.4e-05	0.000883	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.32e-05	0.000863	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.31e-05	0.000861	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—MAPK1—multiple sclerosis	3.3e-05	0.000857	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.26e-05	0.000847	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—MAPK1—multiple sclerosis	3.24e-05	0.000842	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.22e-05	0.000836	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—MAPK1—multiple sclerosis	3.18e-05	0.000827	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—MAPK1—multiple sclerosis	3.11e-05	0.000807	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.09e-05	0.000804	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.09e-05	0.000804	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SRM—multiple sclerosis	3.06e-05	0.000794	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.02e-05	0.000786	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.94e-05	0.000765	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.86e-05	0.000743	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.83e-05	0.000736	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.83e-05	0.000735	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.81e-05	0.00073	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.76e-05	0.000717	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—MAPK1—multiple sclerosis	2.72e-05	0.000706	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.69e-05	0.0007	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.52e-05	0.000654	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.52e-05	0.000654	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.46e-05	0.00064	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.35e-05	0.000612	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.35e-05	0.000609	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.3e-05	0.000599	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.15e-05	0.000559	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.15e-05	0.000559	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.1e-05	0.000547	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.97e-05	0.000511	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.91e-05	0.000496	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.82e-05	0.000473	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.63e-05	0.000424	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.56e-05	0.000406	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.48e-05	0.000385	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.43e-05	0.00037	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.35e-05	0.00035	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.27e-05	0.000331	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.27e-05	0.000329	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.16e-05	0.000301	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000285	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.09e-05	0.000282	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.91e-06	0.000258	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.37e-06	0.000243	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—APOE—multiple sclerosis	8.1e-06	0.000211	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—POMC—multiple sclerosis	6.96e-06	0.000181	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—APOE—multiple sclerosis	6.6e-06	0.000171	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALB—multiple sclerosis	6.35e-06	0.000165	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—POMC—multiple sclerosis	5.67e-06	0.000147	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—APOE—multiple sclerosis	5.64e-06	0.000146	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALB—multiple sclerosis	5.17e-06	0.000134	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—POMC—multiple sclerosis	4.84e-06	0.000126	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALB—multiple sclerosis	4.41e-06	0.000115	CbGpPWpGaD
